Anthem Biosciences Ratios

Anthem Biosciences Ltd Ratios

The Anthem Biosciences Ltd Ratios page provides a complete fundamental analysis of Anthem Biosciences Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Anthem Biosciences Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Anthem Biosciences Ltd (NSE: ANTHEM, BSE: 544449) is currently trading at ₹769.10, with a market capitalization of ₹438.28B. As a major player in the Health technology sector and Biotechnology industry, Anthem Biosciences Ltd remains a key stock for fundamental analysis using Anthem Biosciences Ltd Ratios.

Anthem Biosciences Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Anthem Biosciences Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Anthem Biosciences Ltd Ratios.

Historically, the Anthem Biosciences Ltd P/E ratio has shown strong fluctuations:

• 2023: 0
• 2022: 0
• 2021: 0

The decline in Anthem Biosciences Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Anthem Biosciences Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

• 2023: 0
• 2022: 0
• 2021: 0

Anthem Biosciences Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Anthem Biosciences Ltd P/S ratio currently stands at 0, an important part of Anthem Biosciences Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2023: 0
• 2022: 0
• 2021: 0

A stable or declining Anthem Biosciences Ltd P/S ratio indicates cautious market sentiment.

Anthem Biosciences Ltd Price to Cash Flow Ratio (P/CF)

The Anthem Biosciences Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Anthem Biosciences Ltd Price to Cash Flow Ratio:

• 2023: 0
• 2022: 0
• 2021: 0

The declining Anthem Biosciences Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Anthem Biosciences Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Anthem Biosciences Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

• 2023: 0
• 2022: 0
• 2021: 0

Anthem Biosciences Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Anthem Biosciences Ltd EV/EBITDA ratio is currently 0, a key metric in Anthem Biosciences Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2023: 0
• 2022: 0
• 2021: 0

Stable Anthem Biosciences Ltd EV/EBITDA indicates balanced valuation.

Anthem Biosciences Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Anthem Biosciences Ltd D/E ratio is currently 0.12, reflecting leverage and financial stability.

Historical D/E:

• 2023: 0.12
• 2022: 0.07
• 2021: 0.03

Anthem Biosciences Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Anthem Biosciences Ltd ROE currently stands at 20.04%, showing profitability and capital efficiency.

Historical ROE:

• 2023: 20.04
• 2022: 24.89
• 2021: 0

Anthem Biosciences Ltd demonstrates strong profitability and efficient capital utilization.

Anthem Biosciences Ltd Ratios Analysis Summary

The Anthem Biosciences Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Anthem Biosciences Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Anthem Biosciences Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.